0001437749-23-002358.txt : 20230202 0001437749-23-002358.hdr.sgml : 20230202 20230202154058 ACCESSION NUMBER: 0001437749-23-002358 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230131 FILED AS OF DATE: 20230202 DATE AS OF CHANGE: 20230202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Barrett Elizabeth A. CENTRAL INDEX KEY: 0001764157 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 23580629 MAIL ADDRESS: STREET 1: C/O UROGEN PHARMA LTD. STREET 2: 9 HA'TA'ASIYA STREET CITY: RA'ANANA STATE: L3 ZIP: 4365007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4 1 rdgdoc.xml FORM 4 X0306 4 2023-01-31 0001668243 UroGen Pharma Ltd. URGN 0001764157 Barrett Elizabeth A. 400 ALEXANDER PARK DRIVE PRINCETON NJ 08540 1 Chief Executive Officer Ordinary Shares 2023-01-31 4 M 0 5000 A 313358 D Ordinary Shares 2023-01-31 4 M 0 13333 A 326691 D Restricted Stock Units 2023-01-31 4 M 0 5000 0 D Ordinary Shares 5000 0 D Restricted Stock Units 2023-01-31 4 M 0 13333 0 D Ordinary Shares 13333 13334 D Restricted Stock Units 2023-01-31 4 A 0 75000 0 A Ordinary Shares 75000 75000 D Employee Stock Option (right to buy) 10.39 2023-01-31 4 A 0 125000 0 A 2033-01-31 Ordinary Shares 125000 125000 D Performance Stock Units 2023-01-31 4 A 0 100000 0 A Ordinary Shares 100000 100000 D Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 15,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2021. The reporting person was granted restricted stock units ("RSUs") on January 31, 2021 representing 40,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2022. 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. 1/3 of the shares underlying the stock options will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026. Each performance stock unit ("PSU") represents a contingent right to receive one ordinary share of the Issuer. All shares underlying the performance stock units will vest upon achievement of a corporate milestone event. The performance stock units were approved by the Board of Directors of the Issuer on January 31, 2023. If the performance stock units are not ratified by the Issuer's shareholders at the Issuer's 2023 annual general meeting, the performance stock units will terminate. /s/ Jason D. Smith, Attorney-in-Fact 2023-02-02